1,518
Views
3
CrossRef citations to date
0
Altmetric
Short Communication

Overcoming the imatinib-resistant BCR-ABL mutants with new ureidobenzothiazole chemotypes endowed with potent and broad-spectrum anticancer activity

, , , , , , , & show all
Article: 2189097 | Received 22 Dec 2022, Accepted 04 Mar 2023, Published online: 17 Mar 2023

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.